• Epsilogen awarded £1m grant from Innovate UK pharmatimes
    October 22, 2020
    London-based Epsilogen has been awarded a £1m grant from the UK’s innovation agency Innovate UK to further develop a novel immunoglobulin E (IgE) antibody to treat cancer.
PharmaSources Customer Service